Fluid therapy in critically ill adults with sepsis- Risks and benefits

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-06-16 14:30 GMT   |   Update On 2023-06-16 15:00 GMT
Advertisement

USA: Fluids are one of the essential components in treating critically ill patients with sepsis. The latest review article published in the Journal of the American Medical Association (JAMA) on June 13, 2023 has pointed out how they should be administered in each phase of critical illness.

The researchers suggest "clinicians should consider the benefits and risks of fluid administration in each phase of critical illness, avoid hydroxyethyl starch use, and facilitate fluid removal for patients recovering from acute respiratory distress syndrome." They, however, add that optimal fluid management in sepsis patients remains uncertain.

Advertisement
From the emergency department to the intensive care unit, all critically ill patients with sepsis should be given fluid therapy as fluid administered intravenously can increase cardiac output and blood pressure and maintain or increase intravascular fluid volume.
In this review, the authors summarize the 4 phases of fluid therapy used for critically ill patients with sepsis: resuscitation, optimization, stabilization, and evacuation.
  • A phase 3, randomized clinical trials (RCTs) in which 3723 patients with sepsis who received 1 to 2 L of fluid reported that goal-directed therapy administering fluid boluses did not decrease mortality compared with unstructured clinical care (24.9% vs 25.4%).
  • Another RCT reported that among 1554 patients in the intensive care unit with septic shock treated with at least 1 L of fluid compared with more liberal fluid administration, restricting fluid administration without severe hypoperfusion did not reduce mortality (42.3% vs 42.1%).
  • An RCT of 1000 patients with acute respiratory distress with limited fluid administration and diuretics improved the number of days alive without mechanical ventilation compared with fluid treatment to attain higher intracardiac pressure (14.6 vs 12.1 days).

Based on these various research articles, it can be concluded that although fluid therapy is vital in treating patients who are critically ill with sepsis, it remains uncertain and does not improve mortality with fluid therapy

.Fernando G. Zampieri also noted that clinicians should consider the risks and benefits of fluid administration in each phase of critical illness and facilitate fluid removal for patients recovering from acute respiratory distress syndrome.

Reference:
G Fernando, Sean M,et al. Fluid Therapy for Critically Ill Adults With Sepsis: A Review. JAMA.2023;329(22):1967-1980.


Tags:    
Article Source : Journal of the American Medical Association (JAMA)

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News